share_log

Rodman & Renshaw Initiates Coverage On FibroBiologics With Buy Rating, Announces Price Target of $12

Rodman & Renshaw Initiates Coverage On FibroBiologics With Buy Rating, Announces Price Target of $12

Rodman & Renshaw對FibroBiologics啓動覆蓋,給予買入評級,宣佈目標價爲12美元。
Benzinga ·  12/12 05:03  · 評級/大行評級

Rodman & Renshaw analyst Elemer Piros initiates coverage on FibroBiologics (NASDAQ:FBLG) with a Buy rating and announces Price Target of $12.

羅德曼和倫肖分析師埃勒默·皮羅斯以買入評級啓動了對Fibrobiologics(納斯達克股票代碼:FBLG)的報道,並宣佈目標股價爲12美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論